ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pneumonia Treatment Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-26E1149
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Pneumonia Treatment Drugs Market Research Report 2020
BUY CHAPTERS

Global Pneumonia Treatment Drugs Market Research Report 2025

Code: QYRE-Auto-26E1149
Report
September 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Mylan NV
Novartis
Pfizer Inc
Arsanis
Astrazeneca plc
Combioxin
Shinogi
Sun Pharmaceutical
Medicines
Theravance Biopharma
GlaxoSmithKline
GlaxoSmithKline PLC
MSD
Teva Pharmaceutical

Pneumonia Treatment Drugs Market Size

The global market for Pneumonia Treatment Drugs was valued at US$ 17390 million in the year 2024 and is projected to reach a revised size of US$ 25490 million by 2031, growing at a CAGR of 5.7% during the forecast period.

Pneumonia Treatment Drugs Market

Pneumonia Treatment Drugs Market

Pneumonia is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing cough with phlegm or pus, fever, chills, and difficulty breathing. A variety of organisms, including bacteria, viruses and fungi, can cause pneumonia.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pneumonia Treatment Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pneumonia Treatment Drugs.
The Pneumonia Treatment Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pneumonia Treatment Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pneumonia Treatment Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pneumonia Treatment Drugs Market Report

Report Metric Details
Report Name Pneumonia Treatment Drugs Market
Accounted market size in year US$ 17390 million
Forecasted market size in 2031 US$ 25490 million
CAGR 5.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Macrolides
  • Cephalosporin
  • Penicillin
  • Tetracyclines
  • Fluoroquinolones
  • Vancomycin
  • Other Antibiotics
  • Immunotherapy Drug
  • Vaccines
  • Interferon
Segment by Application
  • Hospital
  • Clinic
  • Drugstore
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, MSD, Mylan, Novartis, Pfizer, Teva Pharmaceutical, Arsanis, AstraZeneca, Combioxin, Shinogi, Sun Pharmaceutical, Medicines, Theravance Biopharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pneumonia Treatment Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pneumonia Treatment Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pneumonia Treatment Drugs Market growing?

Ans: The Pneumonia Treatment Drugs Market witnessing a CAGR of 5.7% during the forecast period 2025-2031.

What is the Pneumonia Treatment Drugs Market size in 2031?

Ans: The Pneumonia Treatment Drugs Market size in 2031 will be US$ 25490 million.

Who are the main players in the Pneumonia Treatment Drugs Market report?

Ans: The main players in the Pneumonia Treatment Drugs Market are GlaxoSmithKline, MSD, Mylan, Novartis, Pfizer, Teva Pharmaceutical, Arsanis, AstraZeneca, Combioxin, Shinogi, Sun Pharmaceutical, Medicines, Theravance Biopharma

What are the Application segmentation covered in the Pneumonia Treatment Drugs Market report?

Ans: The Applications covered in the Pneumonia Treatment Drugs Market report are Hospital, Clinic, Drugstore

What are the Type segmentation covered in the Pneumonia Treatment Drugs Market report?

Ans: The Types covered in the Pneumonia Treatment Drugs Market report are Macrolides, Cephalosporin, Penicillin, Tetracyclines, Fluoroquinolones, Vancomycin, Other Antibiotics, Immunotherapy Drug, Vaccines, Interferon

1 Pneumonia Treatment Drugs Market Overview
1.1 Product Definition
1.2 Pneumonia Treatment Drugs by Type
1.2.1 Global Pneumonia Treatment Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Macrolides
1.2.3 Cephalosporin
1.2.4 Penicillin
1.2.5 Tetracyclines
1.2.6 Fluoroquinolones
1.2.7 Vancomycin
1.2.8 Other Antibiotics
1.2.9 Immunotherapy Drug
1.2.10 Vaccines
1.3 Pneumonia Treatment Drugs by Application
1.3.1 Global Pneumonia Treatment Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drugstore
1.4 Global Pneumonia Treatment Drugs Market Size Estimates and Forecasts
1.4.1 Global Pneumonia Treatment Drugs Revenue 2020-2031
1.4.2 Global Pneumonia Treatment Drugs Sales 2020-2031
1.4.3 Global Pneumonia Treatment Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pneumonia Treatment Drugs Market Competition by Manufacturers
2.1 Global Pneumonia Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pneumonia Treatment Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pneumonia Treatment Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pneumonia Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pneumonia Treatment Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pneumonia Treatment Drugs, Product Type & Application
2.7 Global Key Manufacturers of Pneumonia Treatment Drugs, Date of Enter into This Industry
2.8 Global Pneumonia Treatment Drugs Market Competitive Situation and Trends
2.8.1 Global Pneumonia Treatment Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pneumonia Treatment Drugs Players Market Share by Revenue
2.8.3 Global Pneumonia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pneumonia Treatment Drugs Market Scenario by Region
3.1 Global Pneumonia Treatment Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pneumonia Treatment Drugs Sales by Region: 2020-2031
3.2.1 Global Pneumonia Treatment Drugs Sales by Region: 2020-2025
3.2.2 Global Pneumonia Treatment Drugs Sales by Region: 2026-2031
3.3 Global Pneumonia Treatment Drugs Revenue by Region: 2020-2031
3.3.1 Global Pneumonia Treatment Drugs Revenue by Region: 2020-2025
3.3.2 Global Pneumonia Treatment Drugs Revenue by Region: 2026-2031
3.4 North America Pneumonia Treatment Drugs Market Facts & Figures by Country
3.4.1 North America Pneumonia Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pneumonia Treatment Drugs Sales by Country (2020-2031)
3.4.3 North America Pneumonia Treatment Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pneumonia Treatment Drugs Market Facts & Figures by Country
3.5.1 Europe Pneumonia Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pneumonia Treatment Drugs Sales by Country (2020-2031)
3.5.3 Europe Pneumonia Treatment Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pneumonia Treatment Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Pneumonia Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pneumonia Treatment Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Pneumonia Treatment Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Pneumonia Treatment Drugs Market Facts & Figures by Country
3.7.1 Latin America Pneumonia Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pneumonia Treatment Drugs Sales by Country (2020-2031)
3.7.3 Latin America Pneumonia Treatment Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pneumonia Treatment Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Pneumonia Treatment Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pneumonia Treatment Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pneumonia Treatment Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Pneumonia Treatment Drugs Sales by Type (2020-2031)
4.1.1 Global Pneumonia Treatment Drugs Sales by Type (2020-2025)
4.1.2 Global Pneumonia Treatment Drugs Sales by Type (2026-2031)
4.1.3 Global Pneumonia Treatment Drugs Sales Market Share by Type (2020-2031)
4.2 Global Pneumonia Treatment Drugs Revenue by Type (2020-2031)
4.2.1 Global Pneumonia Treatment Drugs Revenue by Type (2020-2025)
4.2.2 Global Pneumonia Treatment Drugs Revenue by Type (2026-2031)
4.2.3 Global Pneumonia Treatment Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Pneumonia Treatment Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pneumonia Treatment Drugs Sales by Application (2020-2031)
5.1.1 Global Pneumonia Treatment Drugs Sales by Application (2020-2025)
5.1.2 Global Pneumonia Treatment Drugs Sales by Application (2026-2031)
5.1.3 Global Pneumonia Treatment Drugs Sales Market Share by Application (2020-2031)
5.2 Global Pneumonia Treatment Drugs Revenue by Application (2020-2031)
5.2.1 Global Pneumonia Treatment Drugs Revenue by Application (2020-2025)
5.2.2 Global Pneumonia Treatment Drugs Revenue by Application (2026-2031)
5.2.3 Global Pneumonia Treatment Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Pneumonia Treatment Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Pneumonia Treatment Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 MSD
6.2.1 MSD Company Information
6.2.2 MSD Description and Business Overview
6.2.3 MSD Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 MSD Pneumonia Treatment Drugs Product Portfolio
6.2.5 MSD Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Pneumonia Treatment Drugs Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Pneumonia Treatment Drugs Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Company Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Pneumonia Treatment Drugs Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Company Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Teva Pharmaceutical Pneumonia Treatment Drugs Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Arsanis
6.7.1 Arsanis Company Information
6.7.2 Arsanis Description and Business Overview
6.7.3 Arsanis Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Arsanis Pneumonia Treatment Drugs Product Portfolio
6.7.5 Arsanis Recent Developments/Updates
6.8 AstraZeneca
6.8.1 AstraZeneca Company Information
6.8.2 AstraZeneca Description and Business Overview
6.8.3 AstraZeneca Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 AstraZeneca Pneumonia Treatment Drugs Product Portfolio
6.8.5 AstraZeneca Recent Developments/Updates
6.9 Combioxin
6.9.1 Combioxin Company Information
6.9.2 Combioxin Description and Business Overview
6.9.3 Combioxin Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Combioxin Pneumonia Treatment Drugs Product Portfolio
6.9.5 Combioxin Recent Developments/Updates
6.10 Shinogi
6.10.1 Shinogi Company Information
6.10.2 Shinogi Description and Business Overview
6.10.3 Shinogi Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shinogi Pneumonia Treatment Drugs Product Portfolio
6.10.5 Shinogi Recent Developments/Updates
6.11 Sun Pharmaceutical
6.11.1 Sun Pharmaceutical Company Information
6.11.2 Sun Pharmaceutical Description and Business Overview
6.11.3 Sun Pharmaceutical Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sun Pharmaceutical Pneumonia Treatment Drugs Product Portfolio
6.11.5 Sun Pharmaceutical Recent Developments/Updates
6.12 Medicines
6.12.1 Medicines Company Information
6.12.2 Medicines Description and Business Overview
6.12.3 Medicines Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Medicines Pneumonia Treatment Drugs Product Portfolio
6.12.5 Medicines Recent Developments/Updates
6.13 Theravance Biopharma
6.13.1 Theravance Biopharma Company Information
6.13.2 Theravance Biopharma Description and Business Overview
6.13.3 Theravance Biopharma Pneumonia Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Theravance Biopharma Pneumonia Treatment Drugs Product Portfolio
6.13.5 Theravance Biopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pneumonia Treatment Drugs Industry Chain Analysis
7.2 Pneumonia Treatment Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pneumonia Treatment Drugs Production Mode & Process Analysis
7.4 Pneumonia Treatment Drugs Sales and Marketing
7.4.1 Pneumonia Treatment Drugs Sales Channels
7.4.2 Pneumonia Treatment Drugs Distributors
7.5 Pneumonia Treatment Drugs Customer Analysis
8 Pneumonia Treatment Drugs Market Dynamics
8.1 Pneumonia Treatment Drugs Industry Trends
8.2 Pneumonia Treatment Drugs Market Drivers
8.3 Pneumonia Treatment Drugs Market Challenges
8.4 Pneumonia Treatment Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Mylan NV
Novartis
Pfizer Inc
Arsanis
Astrazeneca plc
Combioxin
Shinogi
Sun Pharmaceutical
Medicines
Theravance Biopharma
GlaxoSmithKline
GlaxoSmithKline PLC
MSD
Teva Pharmaceutical
List of Tables
 Table 1. Global Pneumonia Treatment Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pneumonia Treatment Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pneumonia Treatment Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pneumonia Treatment Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pneumonia Treatment Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pneumonia Treatment Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pneumonia Treatment Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pneumonia Treatment Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pneumonia Treatment Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pneumonia Treatment Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pneumonia Treatment Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Pneumonia Treatment Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pneumonia Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Treatment Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pneumonia Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pneumonia Treatment Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pneumonia Treatment Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Pneumonia Treatment Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pneumonia Treatment Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Pneumonia Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pneumonia Treatment Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Pneumonia Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pneumonia Treatment Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Pneumonia Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pneumonia Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pneumonia Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pneumonia Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pneumonia Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pneumonia Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pneumonia Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pneumonia Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pneumonia Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pneumonia Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pneumonia Treatment Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pneumonia Treatment Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pneumonia Treatment Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pneumonia Treatment Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pneumonia Treatment Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pneumonia Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pneumonia Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pneumonia Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pneumonia Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pneumonia Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pneumonia Treatment Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pneumonia Treatment Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pneumonia Treatment Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pneumonia Treatment Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pneumonia Treatment Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pneumonia Treatment Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Pneumonia Treatment Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Pneumonia Treatment Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Pneumonia Treatment Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Pneumonia Treatment Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pneumonia Treatment Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pneumonia Treatment Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Pneumonia Treatment Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Pneumonia Treatment Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Pneumonia Treatment Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Pneumonia Treatment Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Pneumonia Treatment Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Pneumonia Treatment Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Pneumonia Treatment Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Pneumonia Treatment Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pneumonia Treatment Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pneumonia Treatment Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Pneumonia Treatment Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Pneumonia Treatment Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Pneumonia Treatment Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Pneumonia Treatment Drugs Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. MSD Company Information
 Table 76. MSD Description and Business Overview
 Table 77. MSD Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. MSD Pneumonia Treatment Drugs Product
 Table 79. MSD Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Mylan Pneumonia Treatment Drugs Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Pneumonia Treatment Drugs Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Pfizer Company Information
 Table 91. Pfizer Description and Business Overview
 Table 92. Pfizer Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer Pneumonia Treatment Drugs Product
 Table 94. Pfizer Recent Developments/Updates
 Table 95. Teva Pharmaceutical Company Information
 Table 96. Teva Pharmaceutical Description and Business Overview
 Table 97. Teva Pharmaceutical Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Teva Pharmaceutical Pneumonia Treatment Drugs Product
 Table 99. Teva Pharmaceutical Recent Developments/Updates
 Table 100. Arsanis Company Information
 Table 101. Arsanis Description and Business Overview
 Table 102. Arsanis Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Arsanis Pneumonia Treatment Drugs Product
 Table 104. Arsanis Recent Developments/Updates
 Table 105. AstraZeneca Company Information
 Table 106. AstraZeneca Description and Business Overview
 Table 107. AstraZeneca Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. AstraZeneca Pneumonia Treatment Drugs Product
 Table 109. AstraZeneca Recent Developments/Updates
 Table 110. Combioxin Company Information
 Table 111. Combioxin Description and Business Overview
 Table 112. Combioxin Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Combioxin Pneumonia Treatment Drugs Product
 Table 114. Combioxin Recent Developments/Updates
 Table 115. Shinogi Company Information
 Table 116. Shinogi Description and Business Overview
 Table 117. Shinogi Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Shinogi Pneumonia Treatment Drugs Product
 Table 119. Shinogi Recent Developments/Updates
 Table 120. Sun Pharmaceutical Company Information
 Table 121. Sun Pharmaceutical Description and Business Overview
 Table 122. Sun Pharmaceutical Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Sun Pharmaceutical Pneumonia Treatment Drugs Product
 Table 124. Sun Pharmaceutical Recent Developments/Updates
 Table 125. Medicines Company Information
 Table 126. Medicines Description and Business Overview
 Table 127. Medicines Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Medicines Pneumonia Treatment Drugs Product
 Table 129. Medicines Recent Developments/Updates
 Table 130. Theravance Biopharma Company Information
 Table 131. Theravance Biopharma Description and Business Overview
 Table 132. Theravance Biopharma Pneumonia Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Theravance Biopharma Pneumonia Treatment Drugs Product
 Table 134. Theravance Biopharma Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Pneumonia Treatment Drugs Distributors List
 Table 138. Pneumonia Treatment Drugs Customers List
 Table 139. Pneumonia Treatment Drugs Market Trends
 Table 140. Pneumonia Treatment Drugs Market Drivers
 Table 141. Pneumonia Treatment Drugs Market Challenges
 Table 142. Pneumonia Treatment Drugs Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pneumonia Treatment Drugs
 Figure 2. Global Pneumonia Treatment Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pneumonia Treatment Drugs Market Share by Type: 2024 & 2031
 Figure 4. Macrolides Product Picture
 Figure 5. Cephalosporin Product Picture
 Figure 6. Penicillin Product Picture
 Figure 7. Tetracyclines Product Picture
 Figure 8. Fluoroquinolones Product Picture
 Figure 9. Vancomycin Product Picture
 Figure 10. Other Antibiotics Product Picture
 Figure 11. Immunotherapy Drug Product Picture
 Figure 12. Vaccines Product Picture
 Figure 13. Global Pneumonia Treatment Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 14. Global Pneumonia Treatment Drugs Market Share by Application: 2024 & 2031
 Figure 15. Hospital
 Figure 16. Clinic
 Figure 17. Drugstore
 Figure 18. Global Pneumonia Treatment Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Pneumonia Treatment Drugs Market Size (2020-2031) & (US$ Million)
 Figure 20. Global Pneumonia Treatment Drugs Sales (2020-2031) & (K Units)
 Figure 21. Global Pneumonia Treatment Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 22. Pneumonia Treatment Drugs Report Years Considered
 Figure 23. Pneumonia Treatment Drugs Sales Share by Manufacturers in 2024
 Figure 24. Global Pneumonia Treatment Drugs Revenue Share by Manufacturers in 2024
 Figure 25. Global 5 and 10 Largest Pneumonia Treatment Drugs Players: Market Share by Revenue in Pneumonia Treatment Drugs in 2024
 Figure 26. Pneumonia Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. Global Pneumonia Treatment Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 28. North America Pneumonia Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 29. North America Pneumonia Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. U.S. Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Canada Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Europe Pneumonia Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 33. Europe Pneumonia Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 34. Germany Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. France Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. U.K. Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Italy Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Russia Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Asia Pacific Pneumonia Treatment Drugs Sales Market Share by Region (2020-2031)
 Figure 40. Asia Pacific Pneumonia Treatment Drugs Revenue Market Share by Region (2020-2031)
 Figure 41. China Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Japan Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. South Korea Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. India Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Australia Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Taiwan Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Indonesia Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Thailand Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Malaysia Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Philippines Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Latin America Pneumonia Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 52. Latin America Pneumonia Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 53. Mexico Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Brazil Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Argentina Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Pneumonia Treatment Drugs Sales Market Share by Country (2020-2031)
 Figure 57. Middle East and Africa Pneumonia Treatment Drugs Revenue Market Share by Country (2020-2031)
 Figure 58. Turkey Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Saudi Arabia Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. U.A.E Pneumonia Treatment Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 61. Global Sales Market Share of Pneumonia Treatment Drugs by Type (2020-2031)
 Figure 62. Global Revenue Market Share of Pneumonia Treatment Drugs by Type (2020-2031)
 Figure 63. Global Pneumonia Treatment Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 64. Global Sales Market Share of Pneumonia Treatment Drugs by Application (2020-2031)
 Figure 65. Global Revenue Market Share of Pneumonia Treatment Drugs by Application (2020-2031)
 Figure 66. Global Pneumonia Treatment Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 67. Pneumonia Treatment Drugs Value Chain
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Gas Mixtures for Airway Obstruction Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-29F16707
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Asthma Attack Alert System Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-19R17068
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Heated Humidified High-Flow Therapy Systems Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-20V17068
Tue Nov 11 00:00:00 UTC 2025

Add to Cart

Global Computer-based Spirometer Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-36W16800
Mon Nov 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions